Machak GN, Bruland ØS, Romanova TN, Kovalev AV(2024) Denosumab induction and Zoledronic acid maintenance therapy for recurrent unresectable giant cell tumour of the distal tibia: A case report with sustained tumour control after drug withdrawal J Bone Oncol, 45, 100596 DOI 10.1016/j.jbo.2024.100596, PubMed 38545297
Bruland ØS, Larsen RH, Baum RP, Juzeniene A(2023) Editorial: Targeted alpha particle therapy in oncology Front Med (Lausanne), 10, 1165747 DOI 10.3389/fmed.2023.1165747, PubMed 36960341
Fauske L, Jebsen NL, Bondevik H, Bruland ØS(2023) Exploring the Patient Perspective of Bone Sarcoma Survivors Who Have Undergone Particle Radiotherapy Abroad Anticancer Res, 43(5), 2031-2039 DOI 10.21873/anticanres.16364, PubMed 37097689